investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
Naoto Hirano
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Daniela Salvemini
A3AR Agonists to Prevent Chemotherapy-Induced Painful Peripheral Neuropathy
All cancers but non-melanoma skin cancer
Joseph Barchi
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
All cancers but non-melanoma skin cancer
Joel Pearson
Determining the molecular pathways that regulate mammalian cell competition
All cancers but non-melanoma skin cancer
Kerry Courneya
Role of physical activity in the fight against cancer (CANADA RESEARCH CHAIRHOLDER)
All cancers but non-melanoma skin cancer
A. K. M. Nur-Ur Rahman
Defining the role of T cell metabolism in HIV-induced chronic immune activation and immune dysfunction.
All cancers but non-melanoma skin cancer
Sankar Mitra
Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes
All cancers but non-melanoma skin cancer
Radiation Oncology
Jill P Mesirov
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research
All cancers but non-melanoma skin cancer
Maya Shmulevitz
CRC Tier 2 - Human Reovirus
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer